Primary pineal tumors: outcome and prognostic factors - a study from the Rare Cancer Network (RCN)
Clin. transl. oncol. (Print)
; 14(11): 827-834, nov. 2012. tab, ilus
Artigo
em Inglês
| IBECS
| ID: ibc-127055
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
PURPOSE:
To better define outcome and prognostic factors in primary pineal tumors. MATERIALS ANDMETHODS:
Thirty-five consecutive patients from seven academic centers of the Rare Cancer Network diagnosed between 1988 and 2006 were included. Median age was 36 years. Surgical resection consisted of biopsy in 12 cases and resection in 21 (2 cases with unknown resection). All patients underwent radiotherapy and 12 patients received also chemotherapy.RESULTS:
Histological subtypes were pineoblastoma (PNB) in 21 patients, pineocytoma (PC) in 8 patients and pineocytoma with intermediate differentiation in 6 patients. Six patients with PNB had evidence of spinal seeding. Fifteen patients relapsed (14 PNB and 1 PC) with PNB cases at higher risk (p = 0.031). Median survival time was not reached. Median disease-free survival was 82 months (CI 50 % 28-275). In univariate analysis, age younger than 36 years was an unfavorable prognostic factor (p = 0.003). Patients with metastases at diagnosis had poorer survival (p = 0.048). Late side effects related to radiotherapy were dementia, leukoencephalopathy or memory loss in seven cases, occipital ischemia in one, and grade 3 seizures in two cases. Side effects related to chemotherapy were grade 3-4 leucopenia in five cases, grade 4 thrombocytopenia in three cases, grade 2 anemia in two cases, grade 4 pancytopenia in one case, grade 4 vomiting in one case and renal failure in one case.CONCLUSIONS:
Age and dissemination at diagnosis influenced survival in our series. The prevalence of chronic toxicity suggests that new adjuvant strategies are advisable (AU)
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Pinealoma
Tipo de estudo:
Estudo diagnóstico
/
Estudo prognóstico
/
Fatores de risco
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2012
Tipo de documento:
Artigo
Instituição/País de afiliação:
CHUJean Minjoz/France
/
Catalan Institute of Oncology/Spain
/
Centre Hospitalier Universitaire Vaudois/Switzerland
/
Erasmus MC/TheNetherlands
/
Hospital Universitari de Bellvitge/Spain
/
Istanbul Bilim University/Turkey
/
Maastricht University Medical Center (MUMC)/The Netherlands
/
Mayo Clinic/USA
/
University Hospital Maggiore della Caritá/Italy